Umehara H, Okazaki K, Masaki Y et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1–14. https://doi.org/10.3109/s10165-011-0508-6
Perugino CA, Stone JH (2020) IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16:702–714. https://doi.org/10.1038/s41584-020-0500-7
Akiyama M, Alshehri W, Ishigaki S et al (2024) The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics. Immunol Med 1–13. https://doi.org/10.1080/25785826.2024.2407224
Yamada K, Yamamoto M, Saeki T et al (2017) New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther 19:262. https://doi.org/10.1186/s13075-017-1467-x
Article PubMed PubMed Central Google Scholar
Akiyama M, Kaneko Y, Takeuchi T (2019) Characteristics and prognosis of IgG4-related periaortitis/periarteritis: a systematic literature review. Autoimmun Rev 18:102354. https://doi.org/10.1016/j.autrev.2019.102354
de la Fuente J, Bird J (2019) Coronary arteritis in IgG4-Related disease. N Engl J Med 380:2156–2156. https://doi.org/10.1056/NEJMicm1809588
Kawahara H, Mizushima I, Matsumoto Y et al (2023) Solitary recurrence of IgG4-related giant coronary aneurysm: case report and review of the literature focusing on treatment strategies and complications. Mod Rheumatol Case Rep 8:182–194. https://doi.org/10.1093/mrcr/rxad065
Hua T, Du J, Guo X et al (2024) Coronary periarteritis and pericarditis are rare but distinct manifestations of heart involvement in IgG4-related disease: a retrospective cohort study. Orphanet J Rare Dis 19:266. https://doi.org/10.1186/s13023-024-03266-y
Article PubMed PubMed Central Google Scholar
Oyama-Manabe N, Yabusaki S, Manabe O et al (2018) IgG4-related cardiovascular disease from the aorta to the coronary arteries: Multidetector CT and PET/CT. Radiographics 38:1934–1948. https://doi.org/10.1148/rg.2018180049
Fardet L, Fève B (2014) Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs 74:1731–1745. https://doi.org/10.1007/s40265-014-0282-9
Zongfei J, Lingli C, Ying S et al (2022) Clinical and pathological predictors of relapse in IgG4-related disease. Arthritis Res Ther 24:106. https://doi.org/10.1186/s13075-022-02792-z
Article PubMed PubMed Central Google Scholar
Sasaki T, Akiyama M, Kaneko Y et al (2018) Risk factors of relapse following glucocorticoid tapering in IgG4-related disease. Clin Exp Rheumatol 112:186–189
Takanashi S, Akiyama M, Furuhashi K et al (2023) Distinct impact of malignancy and allergy on the clinical and immunological features of IgG4-related disease. https://doi.org/10.55563/clinexprheumatol/7g2na0. Clin Exp Rheumatol
Liu Y, Jin K, Yang Y, Yang A (2024) Efficacy and safety of Rituximab induction therapy and effect of Rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis. Eur J Intern Med 127:63–73. https://doi.org/10.1016/j.ejim.2024.06.006
Umehara H, Okazaki K, Masaki Y et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21–30. https://doi.org/10.1007/s10165-011-0571-z
Benlidayi IC, Gupta L (2024) CAse-BAsed REview sTandards (CABARET): considerations for authors, reviewers, and editors. J Korean Med Sci 39:e225. https://doi.org/10.3346/jkms.2024.39.e225
Article PubMed PubMed Central Google Scholar
Asher A, O’Neill L, Luqmani R (2018) 050 IgG4 related disease causing left anterior descending artery stenosis successfully treated with rituximab therapy. Rheumatology (Oxford) 57:key075.274. https://doi.org/10.1093/rheumatology/key075.274
Goudot G, Yanamandala M, Mitchell R et al (2022) Severe triple vessel disease secondary to IgG4-related coronary periarteritis. J Card Surg 37:5468–5471. https://doi.org/10.1111/jocs.17187
Broderick R, Kazeros A, Beniaminovitz A et al (2018) A unifying diagnosis: IgG4-related disease. Am J Med 131:1449–1451. https://doi.org/10.1016/j.amjmed.2018.07.014
Ibrahim T, Muenzel D, Babaryka G et al (2017) Affection of the cardiovascular system by IgG4-related disease. Eur Heart J Cardiovasc Imaging 18:485. https://doi.org/10.1093/ehjci/jew290
Delgado-García G, Sánchez-Salazar S, Rendón-Ramírez E et al (2016) Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review. Clin Rheumatol 35:2857–2864. https://doi.org/10.1007/s10067-016-3292-z
Zhang Y-J, Chen Y, Zhao X et al (2020) Coronary arteritis and periaortitis in IgG4-related disease. Can J Cardiol 36:589.e5-589.e7. https://doi.org/10.1016/j.cjca.2019.11.028
Tran MN, Langguth D, Hart G et al (2015) IgG4-related systemic disease with coronary arteritis and aortitis, causing recurring critical coronary ischemia. Int J Cardiol 201:33–34. https://doi.org/10.1016/j.ijcard.2015.08.014
Perugino CA, Wallace ZS, Meyersohn N et al (2016) Large vessel involvement by IgG4-related disease. Med (Baltim) 95:e3344. https://doi.org/10.1097/MD.0000000000003344
Wong PCW, Fung AT, Gerrie AS et al (2013) IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol 90:250–256. https://doi.org/10.1111/ejh.12059
Ratwatte S, Day M, Ridley LJ et al (2022) Cardiac manifestations of IgG4-related disease: a case series. Eur Heart J Case Rep 6:ytac153. https://doi.org/10.1093/ehjcr/ytac153
Article PubMed PubMed Central Google Scholar
Cortazar FB, Rhee EP, Gupta S et al (2020) Case 34-2020: a 74-year-old man with chronic kidney disease. N Engl J Med 383:1768–1778. https://doi.org/10.1056/NEJMcpc2002415
Yardimci GK, Ardali Duzgun S, Bolek EC et al (2021) Coronary (peri)-arteritis in patients with IgG4-related disease: a case series from the Central Anatolia Region of Turkey. Int J Rheum Dis 24:1004–1013. https://doi.org/10.1111/1756-185X.14153
Ramdin N, Orde M, O’Neill SB et al (2021) Hidden IgG4-related coronary disease. Am J Clin Pathol 156:471–477. https://doi.org/10.1093/ajcp/aqaa258
de Sainte Marie B, Bonnet G, Gonzalez S et al (2024) Coronary arteritis and aneurysm in a young adult revealing systemic IgG4-related disease. Ann Intern Med Clin Cases 3. https://doi.org/10.7326/aimcc.2023.0846
Chieng ND, Yap J, Lin M (2022) Coronary IgG4: PET pigs in blankets. Circ Cardiovasc Imaging 15:e014314. https://doi.org/10.1161/CIRCIMAGING.122.014314
Lee NJ, Glockner JF (2021) Multisystem IgG4-related disease involving the abdomen and coronary arteries and causing chronic abdominal pain. Acta Radiol Open 10:20584601211044988. https://doi.org/10.1177/20584601211044989
Veeken LD, Opdam MAA, Verhoef LM et al (2024) Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study. Rheumatology (Oxford) 63:1246–1250. https://doi.org/10.1093/rheumatology/kead328
Lu C, Li S, Qing P et al (2023) Single-cell transcriptome analysis and protein profiling reveal broad immune system activation in IgG4-related disease. JCI Insight 8. https://doi.org/10.1172/jci.insight.167602
Mattoo H, Mahajan VS, Maehara T et al (2016) Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol 138:825–838. https://doi.org/10.1016/j.jaci.2015.12.1330
Article PubMed PubMed Central Google Scholar
Wallace ZS, Mattoo H, Carruthers M et al (2015) Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74:190–195. https://doi.org/10.1136/annrheumdis-2014-205233
Della-Torre E, Rigamonti E, Perugino C et al (2020) B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J Allergy Clin Immunol 145:968–981e14. https://doi.org/10.1016/j.jaci.2019.07.004
留言 (0)